
201 - 500 employees
Founded 2020
𧬠Biotechnology
π Pharmaceuticals
π₯ Funding within the last year
π° $500M Post-IPO Debt on 2026-06
Biotechnology β’ Pharmaceuticals
Mineralys Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies that target aldosterone-driven cardio-renal-metabolic diseases. The company is concentrating on improving outcomes for patients with hypertension, chronic kidney disease (CKD), and related disorders caused by dysregulated aldosterone signaling. Its pipeline highlights lorundrostat, an investigational agent aimed at modulating aldosterone biology to treat cardio-renal-metabolic conditions.
π October 29
πΊπΈ United States β Remote
π΅ $215k - $240k / year
β° Full Time
π΄ Lead
π Director
π» Ghost score 0%
Where this job comes from
Posted on Mineralys Therapeutics's careers page β, not through a job board
First seen by Remote Rocketship October 29
Still open on Mineralys Therapeutics's site. Checked 3 hours ago.

201 - 500 employees
Founded 2020
𧬠Biotechnology
π Pharmaceuticals
π₯ Funding within the last year
π° $500M Post-IPO Debt on 2026-06
Biotechnology β’ Pharmaceuticals
Mineralys Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies that target aldosterone-driven cardio-renal-metabolic diseases. The company is concentrating on improving outcomes for patients with hypertension, chronic kidney disease (CKD), and related disorders caused by dysregulated aldosterone signaling. Its pipeline highlights lorundrostat, an investigational agent aimed at modulating aldosterone biology to treat cardio-renal-metabolic conditions.
β’ Provide strategic and technical leadership for analytical activities supporting development, registration, validation, launch, and lifecycle management of the company's small molecule drug substance and drug product portfolio. β’ Set and lead analytical direction across the portfolio using risk-based, phase-appropriate, fit-for-purpose approaches. β’ Serve as the company subject matter expert for analytical chemistry and pharmaceutical analysis. β’ Develop and execute integrated analytical strategies for drug substance, drug product, raw materials, impurities, and reference standards. β’ Own method development, qualification, validation, transfer, verification, and lifecycle management. β’ Establish specifications, impurity control, characterization, reference standards, and stability programs. β’ Lead OOS/OOT investigations, deviations, CAPAs, and complex analytical troubleshooting. β’ Lead selection, governance, and review of external analytical partners, including CDMOs, CROs, and contract testing laboratories. β’ Author, review, and approve analytical content for global regulatory submissions and support Health Authority questions, audits, and inspections. β’ Ensure external partners comply with cGMP requirements, quality agreements, and company standards. β’ Drive analytical readiness for process validation, launch, continued process verification, and post-approval changes. β’ Partner with Drug Substance, Drug Product, Quality, Regulatory, Supply Chain, and Program Management teams on integrated CMC plans. β’ Manage budgets, timelines, resources, and technical risk across programs; build and mentor the team as the organization grows.
β’ Ph.D in Analytical Chemistry, Chemistry, Pharmaceutical Sciences, or a related scientific discipline; an M.S. with substantial directly relevant experience may be considered. β’ Typically 15 or more years of relevant pharmaceutical or biotechnology industry experience, including progressively responsible leadership in analytical development or analytical sciences. β’ Demonstrated experience supporting small molecule products from development through regulatory submission, approval, launch, and commercial lifecycle management. β’ Deep expertise in analytical method development, validation, transfer, stability, specifications, and impurity control for drug substance and drug product. β’ Strong working knowledge of cGMP requirements, ICH guidelines, compendial expectations, data integrity principles, and global CMC regulatory requirements. β’ Proven ability to lead external analytical partners and manage budgets, timelines, and technical risks across multiple programs. β’ Excellent written, verbal, and executive-level communication skills. β’ Up to 10% travel, frequently outside the local area and overnight. β’ Preferred: experience in a virtual, externally networked, or substantially outsourced pharmaceutical operating model. β’ Preferred: experience with oral solid dosage forms, late-stage development, process validation, and commercial launch readiness. β’ Preferred: experience building an Analytical Sciences function and establishing scalable governance and operating processes.
β’ Medical insurance β’ Dental insurance β’ Vision insurance β’ Paid time off β’ 401K β’ Participation in Mineralys incentive plans contingent on achievement of personal and company performance
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
π October 29
Illumina director leading global market access for oncology genomic diagnostics. Shaping reimbursement, evidence, payer engagement, and commercialization strategies worldwide.
πΊπΈ United States β Remote
π΅ $205.1k - $307.7k / year
π° $750M Post-IPO Debt on 2023-01
β° Full Time
π΄ Lead
π Director
π¦ H1B Visa Sponsor
π October 29
Director leading commercial data, advanced analytics, and forecasting at REGENXBIO, a gene therapy company. Building launch-readiness models, forecasts, dashboards, and decision-support capabilities.
πΊπΈ United States β Remote
π΅ $196k - $265k / year
π₯ Funding within the last year
π° $100M Post-IPO Equity on 2026-07
β° Full Time
π΄ Lead
π Director
π October 29
Member relationship director advising insurance and financial services organizations on membership value, growth, and distribution strategy. Leading executive relationships, industry connections, and member engagement.
π October 29
Director leading complex research, evaluation, and advisory engagements for E Source, a utility-industry research, analytics, and technology firm. Managing client relationships, teams, project economics, and business development.
πΊπΈ United States β Remote
π΅ $145k - $193k / year
β° Full Time
π Senior
π΄ Lead
π Director
π October 29
Revenue cycle director leading coding, billing, payer relations, and financial reporting for Oasis Health Partnersβ primary care practices. Managing distributed teams and improving revenue performance for MSO clients.
πΊπΈ United States β Remote
π΅ $110k - $135k / year
π° Seed Round on 2023-01
β° Full Time
π΄ Lead
π Director